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A functional study of mutants of the human immunodeﬁciency virus type 1 (HIV-1) integrase (IN) was
conducted with the support of a recently proposed HIV-1 intasome model. Firstly, we investigated the
predicted position of the C-terminal domain (CTD) and the ﬂexibility of the alpha-6 helix by mutating
the residue Ile-203. This had no impact on the 30-processing reaction but reduced the strand transfer
reaction and the formation of tetramers. Secondly, the residues Ile-141 of the catalytic loop and
Glu-246 of the CTD are predicted to bind the Td-3 base of the viral DNA maintaining it in a ‘‘ﬂipped out’’
position and stabilizing the catalytic core domain (CCD)–CTD interface. Our data showed that the
Ile-141/Td-3 interaction was important for the strand transfer activity and the oligomerization of IN.
Interestingly, mutating the Glu-246 residue by an alanine enhanced half- and full-site integrations,
suggesting that this residue may not be optimized for integration.
& 2013 Elsevier Inc. All rights reserved.Introduction
During retrovirus infection of cells, integration of the retro-
transcribed viral DNA (vDNA) into the host cell chromosome is
mediated by the viral integrase (IN) which recognizes short IN
DNA sequences at the viral DNA ends. The integration process can
be subdivided into three steps: (i) the removal of two terminal
nucleotides from both 30-viral ends to generate the characteristic
CA-30 OH ends, with a two-bases 50-overhang (30-processing
step); (ii) a strand transfer reaction, in which the 30-viral ends
are linked to the host DNA in a transesteriﬁcation reaction.
The host DNA is then asymmetrically cleaved followed by the
insertion of the two viral DNA ends which typically occurs 4–6 bp
apart, according to the retrovirus; (iii) in the third step (gap
ﬁlling), the 50-overhanging dinucleotides of the viral DNA ends
are removed and the single-stranded host DNA gaps are repaired,
creating a short duplication (4–6 bp) of the host sequence.
The integration process is deﬁned as concerted because it enables
the concomitant integration of two viral DNA ends at the same
site of the host cell DNA generating a complete provirus ﬂankedll rights reserved.
).
Lyon, Lyon, France.
Boston, USA.by short host DNA repeats (4–6 bp) whose size is virus speciﬁc
although variations in size lengths have been reported (Colicelli
and Goff, 1988; Moreau et al., 2000; Van Beveren et al., 1982).
The 30-processing and strand transfer steps are catalyzed by
the viral IN enzyme, whereas the repair of gaps in the target DNA
is catalyzed by cellular proteins [For a recent review on retroviral
integration, see (Craigie and Bushman, 2012; Engelman, 2010)].
The retroviral IN protein contains three evolutionarily con-
served and functional domains interconnected with ﬂexible
linkers: the N-terminal domain (NTD), the catalytic core domain
(CCD) and the C-terminal DNA binding domain (CTD), all neces-
sary for the biological activities of the IN protein. This modular
enzyme was proved difﬁcult to crystallize in its entire form. Thus,
X-ray or NMR structures of individual domains or two-domain
fragments were ﬁrst revealed [for review, see (Jaskolski et al.,
2009)]. More recently, the ﬁrst crystal structure of an entire
retroviral IN, that of the prototype foamy virus (PFV) IN com-
plexed with the double-strand vDNA, was determined at 2.9 A˚
resolution (Hare et al., 2010) and was used as a template to
build a 3D model of the HIV-1 intasome (Krishnan et al., 2010).
Its overall architecture with an oblong tetrameric IN enclosing
two ends of viral DNA was different from that expected with
the NTDþCCD and the CCDþCTD two-domain structures
determined to date for the human immunodeﬁciency virus type
1 (HIV-1), simian immunodeﬁciency virus (SIV), Rous sarcoma
Fig. 1. (A) Ribbon representation of the HIV-1 intasome model. The HIV-1 intasome model consists of two symmetric dimers of IN, which assemble at each end of the double-
stranded vDNA. The asymmetric unit of the intasome is composed of two IN monomers (termed A and B) and one vDNA end, made up of the 30-processed DNA single strand of 17
bases in length, and the complementary nonreactive strand of 19 bases in length. Monomer A with its N-terminal (NTD), catalytic core (CCD) and C-terminal (CTD) domains is
highlighted in red, monomer B with its CCD is in dark red (only the CCD of monomer B was visible in the crystal structure of PFV IN and is modeled in HIV-1 IN). The corresponding
monomers C and D are in gray. Monomers A and B interact through a CCD-CCD interface. The monomer A displays an extended conformation with its CTD located between the CCD
and NTD. As concerns the monomer A active site, the bound 30-processed viral DNA end is colored in green and the two catalytic Mg2þ are shown as purple spheres. Monomer B
does not bind the DNA or the vDNA end. The NTD of monomer A interacts with the CCD of the symmetry-related monomer. This NTD also contacts the second vDNA end. The
investigated residues Ile-141, Glu-152, Glu-246 and Ile-203 are shown as yellow sticks with two associated close-up views. (B and C) Two close-up views at the investigated residues
Ile-141, Glu-246 and Ile-203 in the model of HIV-1 intasome. (B) Ile-141 is located at the interface between the CCD (yellow ribbon) and the CTD (red ribbon). Residues within 4 A˚ of
Ile-141 are shown as blue sticks and include Val-259 of the CTD. The aliphatic side chains of Ile-141 and Val-259 are in van derWaals interaction, and themain chain NH of Ile-141 is
hydrogen bonded to the 50-phosphoryl group of the invariant third nucleotide Td3 of the non-reactive viral DNA strand. Another residue of the CCD active loop, N146, is engaged
between Td3 and Ad17 and contacts the purine ring of Ad3 In addition, the ﬁgure shows that the carboxylate group of together with the Lys 215-e–NH3þ of the CCD-CTD linker
binds the pyrimidine ring of the invariant Td3 in the HIV-1 model. The investigated Ile-141 and Glu-246 interact with the invariant nucleotide Td3 of the nonreactive DNA strand,
which is represented as green sticks. The invariant 30 end (invariant Ad17) of the transferred DNA strand is visible near the catalytic residue Glu-152. (C) Ile-203 is located at the end
of helix a6. Residues within 4 A˚ of Ile-203 are shown as green sticks.
C. Cellier et al. / Virology 439 (2013) 97–10498virus (RSV) INs (Chen et al., 2000a, 2000b; Yang et al., 2000). The
crystal structure of the PFV intasome in complex with target DNA
was subsequently elucidated (Maertens et al., 2010) and the
structural basis of the concerted integration mechanism was
established.To further decipher the integration reaction and to add func-
tional data, the use of IN mutants remains interesting biological
tools. Herein, we have analyzed several HIV-1 IN mutants
for integration activities in vitro, as previously performed
for the IN of Avian sarcoma and leukemia viruses, by us
Fig. 2. Catalytic activities of the IN mutants. Catalytic activities were tested using
double-stranded oligonucleotides that mimic the sequence of the viral termini.
Products were analyzed on 12% polyacrylamide-7 M urea denaturating gel,
visualized by autoradiography and quantiﬁed using phosphoimager (see supple-
mentary data 1) Integration efﬁciencies of the WT IN were set at 100%. Results
from each mutant are the mean of at least three experiments. Black circles (K):
not determined.
C. Cellier et al. / Virology 439 (2013) 97–104 99(Charmetant et al., 2011; Moreau et al., 2002, 2003, 2004) and
others (Bojja et al., 2011; Peletskaya et al., 2011). Our analysis
was conducted with the support of the above-mentioned HIV-1
intasome model (Krishnan et al., 2010) (Fig 1A).
Two striking structural features of the PFV-based HIV-1 IN
model have retained our attention: (i) the position of the CTD
between the CCD and the NTD along the two extended monomers
and (ii) a peculiar ‘‘ﬂipped-out’’ conformation of the 50-end of the
nonreactive vDNA strand modeled as observed in PFV IN. Our
mutational approach aimed to further investigate the importance
of the position of the CTD, the CCD-CTD interface and the
ﬂexibility of the alpha 6 helix of HIV-1 IN as well as the
‘‘ﬂipped-out’’ conformation of the vDNA end in IN activities and
IN oligomerization. HIV-1 IN WT protein and six designed IN
mutants (I141K, I203P, I203K, E246K, E246A and E152D (see
below) were generated. The catalytic activities of these IN
proteins (disintegration, 30-processing and strand transfer), their
capacity to mediate concerted (or full-site) integration in vitro,
and their ability to form oligomers by protein–protein cross-
linking were analyzed.Results
Analysis of the HIV-1 intasome model and rationale of mutants
design
The HIV-1 intasome model (Krishnan et al., 2010) consists of
two symmetric dimers of IN, which assemble at each end of the
double-stranded vDNA. In this model, two of the four IN subunits
bind the vDNA made up of the 30-processed DNA. The other two
CCD domains may contribute to the multimerization of IN
(Fig. 1A). In this HIV-1 IN model, two characteristics at the
50-end of the nonreactive vDNA strand and at the DNA binding






GlThe 19-base-long nonreactive vDNA strand begins with ade-
nine Ad-1 at its 50-end. Of particular interest, the third base of
the strand, the invariant thymine Td-3 (Fig. 1B), is comple-
mentary to the sticky base Ad-17 located at the 30–OH end of
the reactive strand. However, no Watson–Crick interaction is
observed between these two invariant bases, Td-3 being
ﬂipped out of the DNA helix and anchored to the CTD, while
Ad-17 interacts with the CCD (Fig. 1B). The peculiar confor-
mation of the phosphodiester backbone at Td-3 involved
interactions with Ile-141 residue main chain as well as
Lys-215 and Glu-246 residues side chains. Interestingly,
Ile-141 is in the ﬂexible CCD active site loop (140–149 in
HIV-1 IN). This loop is found in close proximity to the
catalytic site and its ﬂexibility has been suggested to be
important to IN catalytic activities (Greenwald et al., 1999).
Furthermore, several important residues associated with
in vitro and/or in vivo resistance to raltegravir and/ore 1
dues of the HIV-1 IN intasome model (chain-A and chain-B) close to the
ated residues Ile-141, Ile-203 and Glu-246.




-I141 Gly-140, Pro-142, Tyr-143,
Asn-144 Val-259, Td-3
Non-applicable
-203 Arg-199, Val-201, Asp-202,
Ile-204
Non-applicable
u-246 Lys-215, Thr-218, Gly-245,
Gly-247, Arg-262, Td3
Non-applicableelvitegravir are located in this region (Ceccherini-Silberstein
et al., 2009). Therefore, we designed mutations of Td3-binding
residues. In view of the importance of the CCD active loop in
IN activities and in the assembly of the modeled intasome, we
tested mutants of the Ile-141 and Glu-246 residues. We
analyzed whether the non-equivalent substitution Ile-141 to
Lys (mutant I141K) could alter the IN properties of the IN
complex. Such a drastic mutation (aliphatic to basic, short to
long amino acid) could modify the position of the bound viral
DNA end at this interface as well as the oligomeric status of
the IN complex. The substitution of Glu-246 to Ala (mutant
E246A), which should disrupt the interaction with Td-3 was
also tested, as well as the drastic acidic-to-basic substitution
Glu-246 to Lys (mutant E246K), for comparison.(2) In the two-domain CCD-CTD structures of HIV-1, SIV, and RSV
INs, the arrangement of the CTD relative to the CCD differs
considerably. In the structure containing the CCD-CTD of HIV
IN, the extended alpha-helix 6 that connects the CCD to the
CTD is a canonical cylinder in one monomer and is bent by 451
at Gln-209 in the second monomer (Chen et al., 2000a). In the
HIV-1 model, monomer A continues with a loop that connects
to the CTD and the CTD is not placed at the same position,
while monomer B ends at D202 (Krishnan et al., 2010). Such a
short helix alpha-6 is also observed in the two-domain
structures of SIV and RSV INs (Chen et al., 2000b; Yang
et al., 2000). Interestingly, two experiments strongly
suggested that the binding of DNA to IN provoked movements
of the CTD domains (Zhao et al., 2008; Michel et al., 2009)
and that the protein conformational change involved the
extended alpha-helix 6 (Zhao et al., 2008). Altogether, these
data suggested that the ﬂexibility of the extended helix-6 may
be important to IN activities. Therefore, we mutated the
conserved Ile-203 residue located in the linker between the
CCD and the CTD. Ile-203 is not involved in strong inter-
molecular or intramolecular interactions (Fig. 1C and Table 1).
Thus, the replacement of Ile-203 by a Proline (mutant I203P),
which is an helix-breaker and leads to protein rigidity, was
performed to investigate the inﬂuence of this region on the
CTD ﬂexibility. By contrast, the drastic substitution by a
Lysine (mutant I203K) that replaced an hydrophobic acid
by an hydrophilic one, was aimed to modify the physico–
chemical properties of the helix surface but without blocking
its putative ﬂexibility.Finally, the catalytic Glu-152 was mutated to an inactive form
(mutant E152D) as control.
Fig. 3. Principle of the in vitro concerted DNA integration assay and analysis of the
integration products obtained with the WT IN protein and mutants. (A). Repre-
sentation of the pre-processed donor DNA of 326 bp containing 20 bp of the
terminal U3 att sequence at one end and 20 bp of the U5 att sequence at the other
end. The highly conserved CA dinucleotides are underlined. The closed rectangle
represents the supF tRNA transcription unit. (B). Concerted integration reactions
performed with the WT IN or mutant INs mixed with the pBSK-Zeo acceptor
plasmid and the donor DNA. The reaction products result from either half-site
integration (HSI products) or full-site integration (FSI products) or integration of a
donor DNA into another donor DNA (d/d products). DNA products were analyzed
by agarose gel electrophoresis. Integration products were visualized by autoradio-
graphy and quantiﬁed using a phosphoimager. Next to the gel image are
schematized integration products. (C). Quantiﬁcation of total DNA integration
products (FSIþ HSI and linear FSI products/quantiﬁed on gel) (in gray) and FSI
products (obtained after cloning into bacteria and counting of clones (in black)).
Integration efﬁciencies of the WT IN were set at 100%. Results for mutants are the
mean of at least three experiments.//means that no clones were obtained.
Fig. 4. Analysis of the oligomeric state of WT INs and mutants by protein–protein
cross-linking experiments. (A) Proteins were incubated in the presence of 2 mM of
BS3. [bis (disuccinimidyl suberate)]. Reaction products were analyzed on 8% SDS-PAGE
gel and revealed by silver staining. The migration of cross-linked IN proteins
corresponding to the molecular size of monomers and dimers are indicated. The
molecular size of the monomeric form of IN (with the His Tag) is 36.7 kDa. () and
(þ) BS3: with or without BS3. We also detect a trimeric form in our preparation,
as previously described by others (Krishnan et al., 2010; Li et al., 2012). (B).
The monomers, dimers, trimers, tetramers and higher-order forms were quantiﬁed
by densitometry and are expressed as a percentage of each IN protein. Results shown
are a mean of three experiments.
C. Cellier et al. / Virology 439 (2013) 97–104100Catalytic activities of IN mutants
Catalytic activities (disintegration, 30-processing and strand
transfer activities) of WT and mutant INs were tested in vitro
using double-stranded oligonucleotides that mimic the ﬁnal
20 bp of IN recognition sequences (Supplementary data 1 and
Fig. 2).
The disintegration activity determines whether the mutation
affects the catalytic site. As expected, the disintegration activity
of the E152D catalytic motif mutant was strongly inhibited.
Mutant I203P was quite deﬁcient in performing the disintegration
reaction (23% of the WT), but nevertheless performed the
30-processing of viral end with efﬁciency (100% of the WT
activity) (Fig. 2). Mutant I203K displayed high efﬁciency of
disintegration (77% of the WT IN activity), and elevated 30-
processing activities (157% of the WT). By contrast, both Ile-203
mutants were deﬁcient in strand transfer (14% and 22% for I203P
and I203K, respectively).
The I141K mutant also display this phenotype of being able to
perform disintegration and 30 processing (efﬁciencies of 59% and58% of the WT IN, respectively) with a reduced ability to perform
the strand transfer reaction (17% of the WT IN activity). Finally,
mutants of the Glu-246 residue were able to perform disintegra-
tion with high activities (81% and 67% of the WT IN activity for
E246A and E246K, respectively) (Fig. 2). E246K IN was also able to
perform 30-processing and strand transfer (45% and 70% of WT
activities) while mutant E246A performed both reactions with
elevated activities (125% and 112% of WT activities).Effects of IN mutations on DNA concerted integration
In vitro concerted integration assays allow reproduction of the
integration process as observed in vivo. This assay has allowed
biochemical and biophysical analyses of the HIV integration as
well as to dissect the nucleoprotein complexes intermediates in
HIV integration (Grandgenett et al., 2009; Kessl et al., 2011; Li and
Craigie, 2009; Pandey et al., 2011). The donor DNA (Fig. 3A) was
mixed with a suitable plasmid as acceptor DNA (pBSK-Zeo) and
the recombinant IN enzyme. Products of the integration reaction
(Fig. 3B) arise from: (i) full-site integration (also called two-ended
or concerted integration (Moreau et al., 2003)) generating linear
and circular full-site integration (FSI) products, and (ii) half-site
integration (also called one-ended integration (Moreau et al.,
2003)) generating the circular half-site Integration (HSI) product
(Fig. 3B). By using labeled donor DNA, the integration products
can be separated on agarose gel and visualized by autoradiogra-
phy. Three characteristic bands are revealed (Fig. 3B, lane 1): the
slowest migrating band corresponds to a mix of circular forms
C. Cellier et al. / Virology 439 (2013) 97–104 101(HSI and FSI products), the middle band corresponds to the linear
FSI product and the fastest migrating band corresponds to
donor to donor autointegration products (d/d). As a control, the
reaction was performed without IN: no integration products were
observed (data not shown).
The same reaction was performed with each mutant. For each
of them, the whole integration efﬁciency was determined by
calculating the intensity of bands corresponding to FSI and FSIþ
HSI products and in comparison with the WT protein (Fig. 3C,
gray bars). Accordingly with its defect in the disintegration
activity, E152D mutant had a strongly reduced ability to perform
integration (Fig. 3B, lane 4 and Fig. 3C). I230P (Fig. 3B, lane 2),
I203K (lane 3), and I141K (lane 5) mutants exhibited low inte-
gration activities as observed on gel (Fig. 3B and C) (22%, 18%, 30%,
respectively). Surprisingly, the integration activity of E246A (lane
6) and E246K (lane 7) was higher than that of the WT IN (lane 1)
(115% and 175% that of the WT IN) (Fig. 3).
Subsequently, we focussed on the ability of IN mutants to
speciﬁcally perform full-site integration. Although linear FSI
products are observed gel, the circular FSI products are not well
resolved on gel. Thus, we cloned these products into MC1061/P3
E. coli bacteria (see Materials and methods for details). For each
mutant, the full-site integration efﬁciency was determined by the
number of clones obtained relatively to the number of clones
obtained with the WT IN protein (Fig. 3C, black bars). The E152D
mutant was totally defective for full-site integration (0 clones on
bacteria). Mutants I203P, I203K, I141K as well as mutant E246K
exhibited reduced activity of full-site integration (20%, 29%, 34%
and 46% of WT IN activity, respectively). Unexpectedly, mutant
E246A appeared to be more efﬁcient than the WT IN in catalyzing
full-site integration (166% of the WT IN activity).Effects of IN mutations on IN oligomerization
In protein–protein cross-linking experiments (Fig. 4), INs
were incubated with the BS3 cross-linker. Reaction products
were separated by SDS PAGE and revealed by silver staining.
As expected, in the absence of cross-linker, we observed only the
monomeric form of IN (Fig. 4, lane 1). With WT IN and in presence
of BS3, we detected products at the relative molecular mass
corresponding to the dimers and tetramers of IN and molecular
forms of higher size (lane 2). E246A mutant (lane 7) was present
as high-molecular forms, tetramers and dimers in similar propor-
tions to that of the WT protein (lane 2). For I203K (lane 3), E246K
(lane 8) as well as I141K (lane 6) mutants, the tetrameric form
was slightly less represented for mutants than for the WT protein.
I203P mutant (lane 4) was mainly present as a dimer, whereas
E152D mutant (lane 5) was observed as monomeric, dimeric and
tetrameric forms.
Finally, we tested the capacity of WT and mutants INs to
bind the vDNA by UV cross-linking (Supplementary data 2).
All mutants displayed a reduced efﬁciency of DNA binding com-
pared to the WT IN.Discussion
Flexibility of the alpha-6 helix and position of the CTD
Mutants at the Ile-203 residue were designed to evaluate the
importance of the alpha-6 helix ﬂexibility and of the CTD position
relatively to the CCD, in terms of IN association and enzymatic
activities.
Both the I203P and I203K IN mutants fold mainly as dimeric
forms, although some tetrameric forms were detected for I203K(Fig. 4). These observations suggest that mutation of residue Ile-
203 induced a global conformational change of the IN complex.
Both I203P and I203K mutants performed 30-processing with
high efﬁciency (100 and 157%, respectively) (Fig. 2) and both
mutants formed dimers in absence of any DNA (Fig. 4). This
suggested that a preformed IN dimer is able to perform
30-processing as efﬁciently as the WT IN, which is in agreement
with published data (Faure et al., 2005). Furthermore, it has been
previously shown that the CTD (as well as the NTD) is required for
the 30-processing reaction (in cis or in trans relatively to the active
CCD) (Engelman et al., 1993; van Gent et al., 1993). Thus, our
observations showed that the ﬂexibility of the alpha-6 helix,
putatively blocked in the I203P mutant, was not required for
the 30-processing reaction. Consequently, although the 30-proces-
sing requires the CTD domain, this reaction appeared to not be
dependent of the CTD position and of the ﬂexibility at the alpha-
6 helix.
At the same time, both mutants were defective in performing
strand transfer (Fig. 2), and as a likely consequence (Fig. 2), half-
site and full-site integrations (Fig. 3). The defect in strand transfer
might be related to the absence of tetramers. Alternatively, the
strand transfer reaction might be strongly dependent of the CTD
position.
Interestingly, I203P was also defective in performing the
disintegration process while it maintained its capacity to perform
the 30-processing reaction with efﬁciency (Fig. 2). This could
suggest that the position of the CTD domain resulting from the
introduction of an helix break allowed access to a small DNA at
the catalytic site (the 30-processing DNA). However, access of two
DNAs (the donor and target DNAs in the strand transfer reaction)
or a larger DNA (the disintegration product) to the catalytic site
would be compromised because of steric hindrance.Td-3 binding to the catalytic loop Ile-141 residue
In the HIV-1 intasome model, the residue Ile-141 in the CCD of
monomer A is hydrogen-bonded to the third nucleotide Td-3 of
the nonreactive vDNA strand (Fig. 1B). Thus, Ile-141 could be
involved, at least in part, in the ‘‘ﬂipped-out’’ conformation of this
base (with Glu-246). With this interaction, the ﬂexible loop
bearing Ile-141 is stabilized and is involved in the CCD–CTD
interface of this monomer.
We observed that the substitution of the Ile-141 by a lysine
was associated with a reduction in the formation of tetramers
(Fig. 4). As this residue is not involved in a tetrameric interface,
we speculate that the mutation Ile-141 to Lys provoked a local
perturbation at the CCD–CTD interface of the monomer A which
slightly destabilized the full enzyme.
The mutation caused only a twofold reduction in the disin-
tegration and 30-processing activities (59% and 58%, respectively)
(Fig. 2), suggesting that the Ile-141 interaction with the Td-3 viral
nucleotide is not critical for the reactions of disintegration and 30-
processing.
By contrast, the I141K IN mutant had a reduced ability to
perform the strand transfer reaction (17% of the WT IN activity)
(Fig. 2). As a likely consequence, the I141K IN exhibited low
integration activities as observed on gel (31% that of the WT IN)
and a reduced full-site integration activity (34%) (Fig. 3).
The defect in strand transfer might be related to the absence of
tetramers. Alternatively, since the Ile-141 does not interact with
the target DNA (tDNA) In the HIV-1 intasome model (Krishnan
et al., 2010), the speciﬁc reduction in strand transfer activity of
the I141K mutant may reﬂect the importance of the Ile-141
binding to Td-3 at the time of the strand transfer reaction.
C. Cellier et al. / Virology 439 (2013) 97–104102Td-3 binding to Glu-246
The Glu-246 residue in the CTD has been previously shown to
interact with vDNA (Heuer and Brown, 1997, 1998). In the HIV-1
intasome model, in monomer A, Glu-246 is hydrogen-bonded to the
third nucleotide Td-3 of the nonreactive vDNA strand (Fig. 1B).
In the HIV-1 model, Glu-246 is also in the proximity of the CCD/
CTD interface of the monomer but the residue is not involved in any
dimeric or tetrameric interfaces. Accordingly, E246A mutant was
folded as high-molecular forms, tetramers and dimers in similar
proportions to that of the WT protein. For E246K, the high-
molecular and tetrameric forms were less-represented than for the
WT protein (Fig. 4). As the tetramer was observed in the absence of
any DNA in our experiments, this implies that the binding of Glu-
246 to the viral DNA is not of importance for the stabilization of the
IN tetramers or high-order complexes.
Although the mutants E246A and E246K were active in
performing the three catalytic reactions, the E246K mutant was
overall less efﬁcient than the E246A mutant (Fig. 2). Noticeably,
the E246A mutant was particularly efﬁcient in performing the
two reactions of 30-processing and strand transfer. In accordance
with these data, an E246C IN mutant was also shown to be
efﬁcient in 30-processing and strand transfer (Zhao et al., 2008).
Thus, although the Glu-246 residue is involved in vDNA binding,
the Glu-246/Td-3 interaction may not be fundamental to correctly
position the viral extremity within the catalytic center.
Taken altogether, our data showed that the predicted interac-
tion of GLu-246 with the Td-3 viral nucleotide is not of critical
importance neither for the oligomerization of IN nor for its
catalytic activities. Alternatively, this binding, that was predicted
in the model, may not exist.
Interestingly, both E246A and E246K mutants exhibited a
robust global integration reaction as observed on gel (FSIþHSI)
(Fig. 3B and C) and E246A was even more efﬁcient than the WT IN
in performing the full-site integration reaction (Fig. 3C). One
explanation may be that the glutamate to alanine mutation
liberated the Td-3 base from its ﬂipped out position, thus pro-
moting the full-site integration reaction.
Finally, mutations on the residues Ile-141 and Glu-246
involved in binding the Td-3 base of the vDNA retained their
capacity to carry out the 30-processing reaction (at least with 50%
of the WT IN activity). It is probable that mutating only one
residue out of two was not sufﬁcient for modifying the ‘‘ﬂipped-
out’’ position of the Td-3 base observed in the HIV-1 intasome
model. Alternatively, the ﬂipped-out position of the Td-3 base
may not be correctly positioned in the PFV IN structure-based
HIV-1 IN intasome model. Accordingly, based on data with the
ASV IN, others (Katz et al., 2011) have recently suggested that the
PFV crystal structure may not capture the correct ﬂipped-out
position that occurred in solution.Conclusion
As mentioned above, the two Glu-246 mutants exhibited
a robust global integration reaction. Furthermore, the E246K
mutation had been shown to cause a reduction in Gag protein
processing, in viral particle production because of an excessive
RNA-splicing phenotype (Lu et al., 2005; Mandal et al., 2008). We
had previously described two mutants in the alpha 1-helix of the
CCD of an ASLV IN which surprisingly performed half-site and
full-site integrations with higher efﬁciency than the WT IN
(Moreau et al., 2004). As IN is known to have other functions in
addition to integration in the replication cycle of retroviruses
(Briones et al., 2010; Engelman et al., 1995), these data may
suggest that several IN residues (those whose mutation induced amore active protein for integration in vitro), might be essential for
other functions of IN in the viral replication cycle.Materials and methods
Structure analysis and modeling
The atomic model of the HIV-1 intasome (A. Engelman, personal
communication) was displayed and analyzed on a graphic station
using the program PyMOL (DeLano, 2008). The structures of each
single point mutants were generated with the graphics program
COOT (Emsley and Cowtan, 2004) and idealized with the macro-
molecular reﬁnement program REFMAC (CCP4). These six models
were used with extreme caution for discussion because they were
modeled from a putative model (i.e. of the HIV-1 intasome).
Puriﬁcation of proteins
The gene coding for IN of HIV-1 was ampliﬁed by PCR from the
pNL4.3 plasmid, and cloned into the pET15b plasmid (Novagen)
downstream of a six histidine tag. Cloned IN sequences were
checked by sequencing. Mutants of IN HIV-1 were produced using
quick-change site-directed mutagenesis kit (Stratagene) by PCR
ampliﬁcation of the pET15b-IN circular plasmid with two com-
plementary primers carrying the identical mutation. Sequences
were checked by sequencing. Proteins from pET15b IN and
derivatives were then expressed in E. Coli BL21(DE3)pLysS
(Invitrogen) by 3 h IPTG (1 mM) induction. For puriﬁcation,
protocol was adapted from that of Yi et al. (1999) but beta-
mercaptoethanol (5 mM) was added throughout the puriﬁcation
process. At the end of puriﬁcation, IN proteins were dialyzed
against 20 mM Hepes pH 7.5, 1 M KCl, 5 mM beta-mercaptoetha-
nol, 10% glycerol and stored at 80 1C.
Catalytic activities assays
The following primers which mimic the HIV-1 U5 terminal
sequence were used: U5-HIV (50-TATGCTAGAGATTTTCCACA-30)
and U5C-HIV (50-TGTGGAAAATCTCTAGCATA-30) for the 30 proces-
sing reaction; U5-HIV and U5L-HIV (50-TGTGGAAAATCTCTAGCA-
30) for the strand transfer reaction and U5-HIV, U5D-HIV
(50-TGTGGAAAATCTCTAGCAGGCTCCAGGTCGAC-30), D1-HIV (50-CAG-
CAACGCAAGCTTG-30), D2-HIV (50-GTCGACCTGGAGCCCAAGCTTG-
CGTTGCTG-30) for the disintegration reaction. 50-end labeled
double-stranded primers were prepared as previously described
(Moreau et al., 2004). The 10 ml reaction solution contains
1 pmole of double-stranded primers, 250 ng of puriﬁed protein
and 20 mM HEPES pH 7.5, 10 mM DTT, 0.05% NP40, 7.5 mM
MnCl2 for the 3
0 processing and disintegration reactions or
20 mM HEPES pH7.5, 1 mM DTT, 15 mM MnCl2, 15% DMSO, 8%
PEG8000, 50 mM NaCl for the strand transfer reaction. Reactions
were conducted during 90 min at 37 1C and stopped by addition
of loading buffer. Products were analyzed on 12% polyacrylamide-
7 M urea denaturating gel, visualized by autoradiography and
quantiﬁed using phosphoimager.
DNAs for the integration reactions
The pBSK-Zeo receptor and pBSK-supF plasmids DNA was
previously described (Moreau et al., 2004). The amber mutation
suppressor gene (supF) sequence was ampliﬁed by PCR from
pBSK-supF plasmid using H-U5 (5-GGAATTCCATATGCTAGAG-
ATTTTCCACAGCGGCGCGTCATTTGATATGATGCG-30) and H-U3 (50-
GGAATTCCATATGGAAGGGCTATTTCACTTAACGTTGCCCGGATCCG-
GTCGCGC-30) primers containing the 20 terminal bp of U5 and
C. Cellier et al. / Virology 439 (2013) 97–104 103U3 HIV-1 sequences (sequences underlined). The PCR product
was digested with NdeI enzyme (NdeI sequence of primers is in
italic) and cloned into pUC19 plasmid previously digested with
the same enzyme. The pUC19-supF plasmid was then ampliﬁed
into JM109 bacteria (Promega). The donor DNA used in the
integration reaction was obtained by NdeI digestion of the
pUC19-supF plasmid and gel puriﬁcation of the U3-supF-U5
fragment. When necessary, donor DNA was radiolabeled, as
previously described (Moreau et al., 2004).Integration reaction
A total of 250 ng of puriﬁed IN protein was incubated 30 min
on ice with 100 ng of pBSK-zeo plasmid and 10 ng of donor DNA
in a ﬁnal volume of 5 ml. The volume of reaction was then
increased to 20 ml with ﬁnal concentration of 20 mM Hepes pH
7.5, 50 mM NaCl, 15 mM MnCl2, 15% DMSO, 8% PEG 8000 and
1 mM DTT, and the integration mixture was incubated at 37 1C for
an hour and a half.Gel analysis of the integration products
For gel analysis, the integration reaction was conducted with
radiolabeled donor DNA. After the integration reaction was
performed, the volume was increased to 50 ml with the addition
of 4.25 mM of EDTA, 0.44% of SDS and 20 ng of proteinase K
(Roche diagnostics). The solution was incubated 1 h at 55 1C. The
DNAs were then deproteinized by phenol–chloroform extraction
and puriﬁed by ethanol precipitation. Samples were then loaded
on 1.2% agarose gel in 0.5 TBE. After electrophoresis, the gels
were ﬁxed in a 5% TCA solution for 30 min and dried for 3 h at
45 1C. Integration products were visualized by autoradiography
and quantiﬁed using a phosphoimager (Biorad).Cloning of full-site integration products
A scale up of the integration reaction was performed in the
presence of non-radiolabeled donor DNA. In order to clone all full-
site integration (FSI) products (both linear and circular), the
reaction products were puriﬁed on a Qiaquick column (Qiagen)
and digested with BamHI enzyme (Biolabs). An unique BamHI site
is present only in donor DNA: this leads to linearization of FSI
products, whereas the half-integration site (HIS) product remains
circular. After ligation (to recircularize the FSI linear products),
the whole reaction was used to transform E. Coli MC1060/P3
bacteria (Invitrogen) as previously described (Moreau et al.,
2004). Integration clones carrying the supF gene were then
selected in the presence of 40 mg/ml of ampicillin, 10 mg/ml of
tetracyclin, 15 mg/ml of kanamycin, and 25 mg/ml of zeocin.
Therefore, the cloning analysis enables an estimation of the
efﬁciency of IN proteins to mediate full-site integration. Results
of reactions with mutants IN were compared to that of WT, for
which 100% correspond to 98–320 colonies per plate (according
to the experiments) derived from reaction products with WT IN.Protein–protein cross-linking
WT or mutant INs were treated with 2mM of BS3 [bis (disucci-
nimidyl suberate)] (Pierce) as previously described (Moreau et al.,
2004). Covalently linked multimers were detected by separation on
8% SDS-PAGE and silver staining.Acknowledgments
This work was supported by research grants from the Institut
National de la Recherche Agronomique, and from Re´gion Rhoˆne-
Alpes (Emergence grant; fellowships from cluster 10 for AB).
We thank A. Engelman for providing us the atomic model of the
HIV-1 intasome. We also thank Dr A. Chaboud and the PAP platform
(Production et Analyse de Proteines) of the UMS3444/US8 Bios-
ciences Gerland-Lyon Sud (www.ifr128.prd.fr/) for technical sup-
port. Thanks are also due to Dr SawSee Hong for discussion as well
as proofreading the article and correcting the English.Appendix A. Supporting information
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.virol.2013.02.
001.References
Bojja, R.S., Andrake, M.D., Weigand, S., Merkel, G., Yarychkivska, O., Henderson, A.,
Kummerling, M., Skalka, A.M., 2011. Architecture of a full-length retroviral
integrase monomer and dimer, revealed by small angle X-ray scattering and
chemical cross-linking. J. Biol. Chem 286 (19), 17047–17059.
Briones, M.S., Dobard, C.W., Chow, S.A., 2010. Role of human immunodeﬁciency
virus type 1 integrase in uncoating of the viral core. J. Virol. 84 (10),
5181–5190.
Ceccherini-Silberstein, F., Malet, I., D’Arrigo, R., Antinori, A., Marcelin, A.G., Perno,
C.F., 2009. Characterization and structural analysis of HIV-1 integrase con-
servation. AIDS Rev. 11 (1), 17–29.
Charmetant, J., Moreau, K., Gallay, K., Ballandras, A., Gouet, P., Ronfort, C., 2011.
Functional analyses of mutants of the central core domain of an Avian
sarcoma/leukemia virus integrase. Virology 421 (1), 42–50.
Chen, J.C., Krucinski, J., Miercke, L.J., Finer-Moore, J.S., Tang, A.H., Leavitt, A.D.,
Stroud, R.M., 2000a. Crystal structure of the HIV-1 integrase catalytic core and
C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. U. S.
A. 97 (15), 8233–8238.
Chen, Z., Yan, Y., Munshi, S., Li, Y., Zugay-Murphy, J., Xu, B., Witmer, M., Felock, P.,
Wolfe, A., Sardana, V., Emini, E.A., Hazuda, D., Kuo, L.C., 2000b. X-ray structure
of simian immunodeﬁciency virus integrase containing the core and C-
terminal domain (residues 50-293)—an initial glance of the viral DNA binding
platform. J. Mol. Biol. 296 (2), 521–533.
Colicelli, J., Goff, S.P., 1988. Isolation of an integrated provirus of Moloney murine
leukemia virus with long terminal repeats in inverted orientation: integration
utilizing two U3 sequences. J. Virol. 62 (2), 633–636.
Craigie, R., Bushman, F.D., 2012. HIV DNA Integration. Cold Spring Harb. Perspect.
Med. 2 (7), a006890.
DeLano, W.L., 2008. The PyMol Molecular Graphics Systems. The PyMOL User’s
Manual DeLano Scientiﬁc, LLC, Palo Alto, CA, USA.
Emsley, P., Cowtan, K., 2004. Coot: model-building tools for molecular graphics.
Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132, Pt 12 Pt 1.
Engelman, A., 2010. Reverse transcription and integration. In: Kurth, R., Bannert, N.
(Eds.), Retroviruses: Molecular biology, Genomics and Pathogenesis. Caister
Academic Press, Norfolk, UK, pp. 129–159.
Engelman, A., Bushman, F.D., Craigie, R., 1993. Identiﬁcation of discrete functional
domains of HIV-1 integrase and their organization within an active multimeric
complex. EMBO J. 12 (8), 3269–3275.
Engelman, A., Englund, G., Orenstein, J.M., Martin, M.A., Craigie, R., 1995. Multiple
effects of mutations in human immunodeﬁciency virus type 1 integrase on
viral replication. J. Virol. 69 (5), 2729–2736.
Faure, A., Calmels, C., Desjobert, C., Castroviejo, M., Caumont-Sarcos, A., Tarrago-
Litvak, L., Litvak, S., Parissi, V., 2005. HIV-1 integrase crosslinked oligomers are
active in vitro. Nucleic Acids Res. 33 (3), 977–986.
Grandgenett, D.P., Bera, S., Pandey, K.K., Vora, A.C., Zahm, J., Sinha, S., 2009.
Biochemical and biophysical analyses of concerted (U5/U3) integration.
Methods 47 (4), 229–236.
Greenwald, J., Le, V., Butler, S.L., Bushman, F.D., Choe, S., 1999. The mobility of an
HIV-1 integrase active site loop is correlated with catalytic activity. Biochem-
istry 38 (28), 8892–8898.
Hare, S., Gupta, S.S., Valkov, E., Engelman, A., Cherepanov, P., 2010. Retroviral
intasome assembly and inhibition of DNA strand transfer. Nature 464 (7289),
232–236.
Heuer, T.S., Brown, P.O., 1997. Mapping features of HIV-1 integrase near selected
sites on viral and target DNA molecules in an active enzyme-DNA complex by
photo-cross-linking. Biochemistry 36 (35), 10655–10665.
C. Cellier et al. / Virology 439 (2013) 97–104104Heuer, T.S., Brown, P.O., 1998. Photo-cross-linking studies suggest a model for the
architecture of an active human immunodeﬁciency virus type 1 integrase-DNA
complex. Biochemistry 37 (19), 6667–6678.
Jaskolski, M., Alexandratos, J.N., Bujacz, G., Wlodawer, A., 2009. Piecing together
the structure of retroviral integrase, an important target in AIDS therapy. FEBS
J. 276 (11), 2926–2946.
Katz, R.A., Merkel, G., Andrake, M.D., Roder, H., Skalka, A.M., 2011. Retroviral integrases
promote fraying of viral DNA ends. J Biol. Chem. 286 (29), 25710–25718.
Kessl, J.J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J.O., Feng, L., Musier-Forsyth, K.,
Craigie, R., Kvaratskhelia, M., 2011. FRET analysis reveals distinct conforma-
tions of IN tetramers in the presence of viral DNA or LEDGF/p75. Nucleic Acids
Res. 39 (20), 9009–9022.
Krishnan, L., Li, X., Naraharisetty, H.L., Hare, S., Cherepanov, P., Engelman, A., 2010.
Structure-based modeling of the functional HIV-1 intasome and its inhibition.
Proc. Natl. Acad. Sci. U. S. A. 107 (36), 15910–15915.
Li, M., Craigie, R., 2009. Nucleoprotein complex intermediates in HIV-1 integration.
Methods 47 (4), 237–242.
Li, X., Koh, Y., Engelman, A., 2012. Correlation of recombinant integrase activity
and functional preintegration complex formation during acute infection by
replication-defective integrase mutant human immunodeﬁciency virus.
J. Virol. 86 (7), 3861–3879.
Lu, R., Limon, A., Ghory, H.Z., Engelman, A., 2005. Genetic analyses of DNA-binding
mutants in the catalytic core domain of human immunodeﬁciency virus type
1 integrase. J. Virol. 79 (4), 2493–2505.
Maertens, G.N., Hare, S., Cherepanov, P., 2010. The mechanism of retroviral
integration from X-ray structures of its key intermediates. Nature 468
(7321), 326–329.
Mandal, D., Feng, Z., Stoltzfus, C.M., 2008. Gag-processing defect of human
immunodeﬁciency virus type 1 integrase E246 and G247 mutants is caused
by activation of an overlapping 50 splice site. J. Virol. 82 (3), 1600–1604.
Michel, F., Cruciﬁx, C., Granger, F., Eiler, S., Mouscadet, J.F., Korolev, S., Agapkina, J.,
Ziganshin, R., Gottikh, M., Nazabal, A., Emiliani, S., Benarous, R., Moras, D.,
Schultz, P., Ruff, M., 2009. Structural basis for HIV-1 DNA integration in the
human genome, role of the LEDGF/P75 cofactor. Embo J. 28 (7), 980–991.
Moreau, K., Faure, C., Verdier, G., Ronfort, C., 2002. Analysis of conserved and non-
conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses)
integrase functions in vitro. Arch. Virol. 147 (9), 1761–1778.Moreau, K., Faure, C., Violot, S., Gouet, P., Verdier, G., Ronfort, C., 2004. Mutational
analyses of the core domain of Avian leukemia and sarcoma viruses integrase:
critical residues for concerted integration and multimerization. Virology 318
(2), 566–581.
Moreau, K., Faure, C., Violot, S., Verdier, G., Ronfort, C., 2003. Mutations in the
C-terminal domain of ALSV (Avian Leukemia and Sarcoma Viruses) integrase
alter the concerted DNA integration process in vitro. Eur. J. Biochem. 270 (22),
4426–4438.
Moreau, K., Torne-Celer, C., Faure, C., Verdier, G., Ronfort, C., 2000. In vivo
retroviral integration: ﬁdelity to size of the host DNA duplication might be
reduced when integration occurs near sequences homologous to LTR ends.
Virology 278 (1), 133–136.
Pandey, K.K., Bera, S., Grandgenett, D.P., 2011. The HIV-1 integrase monomer
induces a speciﬁc interaction with LTR DNA for concerted integration.
Biochemistry 50 (45), 9788–9796.
Peletskaya, E., Andrake, M., Gustchina, A., Merkel, G., Alexandratos, J., Zhou, D.,
Bojja, R.S., Satoh, T., Potapov, M., Kogon, A., Potapov, V., Wlodawer, A., Skalka,
A.M., 2011. Localization of ASV integrase-DNA contacts by site-directed
crosslinking and their structural analysis. PLoS One 6 (12), e27751.
Van Beveren, C., Rands, E., Chattopadhyay, S.K., Lowy, D.R., Verma, I.M., 1982. Long
terminal repeat of murine retroviral DNAs: sequence analysis, host- proviral
junctions, and preintegration site. J. Virol. 41 (2), 542–556.
van Gent, D.C., Vink, C., Groeneger, A.A., Plasterk, R.H., 1993. Complementation
between HIV integrase proteins mutated in different domains. Embo J. 12 (8),
3261–3267.
Yang, Z.N., Mueser, T.C., Bushman, F.D., Hyde, C.C., 2000. Crystal structure of an
active two-domain derivative of Rous sarcoma virus integrase. J. Mol. Biol. 296
(2), 535–548.
Yi, J., Asante-Appiah, E., Skalka, A.M., 1999. Divalent cations stimulate preferential
recognition of a viral DNA end by HIV-1 integrase. Biochemistry 38 (26),
8458–8468.
Zhao, Z., McKee, C.J., Kessl, J.J., Santos, W.L., Daigle, J.E., Engelman, A., Verdine, G.,
Kvaratskhelia, M., 2008. Subunit-speciﬁc protein footprinting reveals signiﬁ-
cant structural rearrangements and a role for N-terminal Lys-14 of HIV-1
Integrase during viral DNA binding. J. Biol. Chem. 283 (9), 5632–5641.
